Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Shares Acquired by Vanguard Group Inc.
Vanguard Group Inc. increased its stake in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 1.0% during the 4th quarter, Holdings Channel reports. The fund owned 9,721,360 shares of the biopharmaceutical company’s stock after purchasing an additional 93,107 shares during the quarter. Vanguard Group Inc. owned approximately 0.09% of Intra-Cellular Therapies worth $811,928,000 […]
